Sunday, June 1, 2025

Latest

Harvest Health: Second Quarter Consensus Estimates

Harvest Health and Recreation (CSE: HARV) announced that they will be reporting their second quarter financials after the market closes on August 10.

Analysts have a consensus C$7 12-month price target on the company, via a total of 5 analysts, with one analyst having a strong buy rating, and the other 4 analysts having buy ratings. The street high comes from Alliance Global Partners with a C$9.50 price target, and the lowest target comes from Stifel-GMP with a C$5.50 price target.

Currently 4 analysts have revenue estimates for the second quarter. The mean between all 4 is $97.08 million; this number has been revised slightly higher from $87.08 million at the start of the year. The street high is $98.60 million while the lowest sits at $95.72 million.

Two analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 50.55%, with this number being revised slightly downwards from 51.70% at the start of the year. Street high goes to Stifel-GMP with a 53.50% estimate and the lowest sits at 47.60%.

Onto EBITDA estimates, there are currently 3 analysts who have second quarter EBITDA estimates. The mean is currently $26.82 million, with this number being higher than at the start of the year. Street high goes to Alliance Global with a $28.27 million EBITDA estimate and the lowest being a $26 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

PharmaTher: Maxim Initiates Coverage With US$1.50 Price Target

PharmaTher Holdings (CSE: PHRM) had its first initiation report that came out on June 28th....

Wednesday, June 30, 2021, 02:38:00 PM

Haywood Initiates Coverage On Cresco Labs With $14.00 Price Target

Last week, Haywood Securities initiated coverage on Cresco Labs (CSE: CL) with a C$14.00 price...

Wednesday, November 4, 2020, 01:59:00 PM

Unity Software: Analysts Anticipate $216.6 Million In Q1 Revenues

Unity Software (NYSE: U) will be reporting their first-quarter financial results this evening after market...

Tuesday, May 11, 2021, 02:44:00 PM

Amazon: BMO Lifts Price Target Following Earnings Preview

Amazon (NASDAQ: AMZN), one of the softest hit names during this market sell-off, is expected...

Monday, April 25, 2022, 02:58:00 PM

BMO Expects Miners To Be Hit With Cost Inflation Headwinds In Q1 Results

On April 18, BMO released their first quarter preview on their metals and mining coverage,...

Thursday, April 21, 2022, 11:28:00 AM